Patent details

EP1337525 Title: PROCESS FOR THE CRYSTALLIZATION OF (R)- OR (S)-LANSOPRAZOLE

Basic Information

Publication number:
EP1337525
PCT Application Number:
PCT/JP/2001/010462
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP019985456
PCT Publication Number:
WO/2002/044167
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PROCESS FOR THE CRYSTALLIZATION OF (R)- OR (S)-LANSOPRAZOLE
French Title of Invention:
PROCEDE DE CRISTALLISATION DU (R)- OU DU (S)-LANSOPRAZOLE
German Title of Invention:
VERFAHREN ZUR KRISTALLISATION VON (R)- ODER (S)-LANSOPRAZOL
SPC Number:

Dates

Filing date:
30/11/2001
Grant date:
01/06/2011
EP Publication Date:
01/06/2011
PCT Publication Date:
06/06/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/08/2003
EP B1 Publication Date:
01/06/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
30/11/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/11/2001
 
 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka 541-0045, Japan (JP)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
03/08/2011
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
HASHIMOTO Hideo c/o Takeda Pharmaceutical Company Limited
Address:
Japan (JP)

2

Name:
URAI Tadashi
Address:
Japan (JP)

Priority

Priority Number:
2000367757
Priority Date:
01/12/2000
Priority Country:
Japan (JP)

Classification

Main IPC Class:
C07D 401/12;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
10/11/2020
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages